Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator
- 1 April 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 329 (1) , 230-236
- https://doi.org/10.1016/j.bbrc.2005.01.116
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (JSPS-RFTF97L00593)
This publication has 31 references indexed in Scilit:
- An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 responseJournal of General Virology, 2003
- CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic MiceJournal of Virology, 2001
- Now I know my CpGsTrends in Microbiology, 2001
- CpG DNA as a Th1 TriggerInternational Archives of Allergy and Immunology, 2000
- CpG DNA as mucosal adjuvantVaccine, 1999
- Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-γ-dependent mechanismsProceedings of the National Academy of Sciences, 1999
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Intermediates in influenza virus PR/8 haemagglutinin-induced membrane fusionJournal of General Virology, 1994
- DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor GrowthMicrobiology and Immunology, 1992
- Plaque assay and primary isolation of influenza a viruses in an established line of canine kidney cells (MDCK) in the presence of trypsinMedical Microbiology and Immunology, 1975